Timolol eye drops alleviated the pain in most patients with migraines, according to a small study recently published in JAMA Neurology.
“Several oral [beta]-blockers are U.S. Food and Drug Administration-approved for migraine prophylaxis, but their gradual absorption and modification by first-pass metabolism delays effective plasma levels for hours to days, limiting their use in acute migraines,” Matthew Cossack, MD, of the University of Missouri, Kansas City School of Medicine, and colleagues wrote.
This activity is supported by educational funding provided by Amarin Pharma Inc., Amgen, and Quest Diagnostics.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.